dimethyl sulfoxide has been researched along with Breast Neoplasms in 51 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the current study, we analyzed the combinatorial effect of MSM and tamoxifen on the suppression of ER-positive breast cancer xenograft growth and metastasis." | 7.81 | The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts. ( Chang, SH; Cho, BW; Darvin, P; Hwang, TS; Joung, YH; Kang, DY; Kim, DN; Kim, HS; Kim, SY; Kim, WS; Lee, HK; Park, JH; Park, KD; S P, N; Yang, YM; Yoo, YB, 2015) |
| "To determine the in vitro effects of simultaneously administered LY29400, PD98059, tamoxifen and eicosapentaenoic acid (EPA) on breast cancer cells, and determine their transcutaneous delivery." | 7.74 | In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin. ( Davison, Z; Dutkowski, C; Gee, JM; Heard, CM; Nicholson, RI, 2008) |
| " Gemcitabine is a rather new anti-cancer agent, which is quite potent against a range of drug resistant tumors, particularly breast cancer." | 7.72 | Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro. ( Altinoz, MA; Bilir, A; Guneri, AD, 2004) |
| "We report on a 63-year-old female patient with breast cancer treated with epirubicin combination therapy." | 4.90 | Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature. ( Aigner, B; Arzberger, EJ; Bauernhofer, T; Niederkorn, A; Petru, E; Richtig, E, 2014) |
| "We evaluate the effect of curcumin-loaded lipid-core nanocapsules, curcumin-loaded nanoemulsion and curcumin DMSO-water solution on viability and colony forming efficiency of human breast cancer cell line, MCF7." | 3.85 | Drug-loaded nanoemulsion as positive control is an alternative to DMSO solutions for in vitro evaluation of curcumin delivery to MCF-7 cells. ( Beck, RCR; Buss, J; Collares, T; Coradini, K; da Silva, LP; Dos Santos Chaves, P; Guterres, SS; Pohlmann, AR; Schultze, E; Seixas, FK, 2017) |
| "In the current study, we analyzed the combinatorial effect of MSM and tamoxifen on the suppression of ER-positive breast cancer xenograft growth and metastasis." | 3.81 | The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts. ( Chang, SH; Cho, BW; Darvin, P; Hwang, TS; Joung, YH; Kang, DY; Kim, DN; Kim, HS; Kim, SY; Kim, WS; Lee, HK; Park, JH; Park, KD; S P, N; Yang, YM; Yoo, YB, 2015) |
| "To determine the in vitro effects of simultaneously administered LY29400, PD98059, tamoxifen and eicosapentaenoic acid (EPA) on breast cancer cells, and determine their transcutaneous delivery." | 3.74 | In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin. ( Davison, Z; Dutkowski, C; Gee, JM; Heard, CM; Nicholson, RI, 2008) |
| "Saline-treated control (n = 8) and DMSO-treated (n = 7) human breast cancer xenografts (MDA-MB-435) in rats were imaged dynamically by MMCM-enhanced MRI using albumin-(Gd-DTPA)27-(biotin)11 (molecular weight approximately 90 kDa), before and after a 1-week, 3-dose treatment course." | 3.74 | Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature. ( Brasch, RC; Chaopathomkul, B; Cyran, CC; Fu, Y; McDonald, DM; Rogut, V; Sennino, B; Shames, DM; Wendland, MF, 2008) |
| " Gemcitabine is a rather new anti-cancer agent, which is quite potent against a range of drug resistant tumors, particularly breast cancer." | 3.72 | Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro. ( Altinoz, MA; Bilir, A; Guneri, AD, 2004) |
| "Stage III and IV breast cancer patients received induction chemotherapy with three cycles of CEF (cyclophosphamide 600 mg/m2, epirubicin 100 mg/m2, 5-fluorouracil 600 mg/m2) followed by three cycles of HDC consisting of escalating doses of cyclophosphamide (dose range 1200 3000 mg/m2) and carboplatin (dose range 600-1000 mg/m2), supported by DMSO-free PBPC reinfusion." | 3.71 | Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. ( Bergaglio, M; Bertelli, G; Bertoglio, S; Bighin, C; Del Mastro, L; Lambiase, A; Melioli, G; Pietra, G; Rosso, R; Semino, C; Sertoli, MR; Signorini, A; Venturini, M; Viscoli, C, 2001) |
| " Furthermore, it leads to a safe and sustained engraftment." | 2.71 | The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. ( Bewick, M; Chadderton, T; Glück, S; Porter, K; Stewart, D; Syme, R, 2004) |
| "When comparing breast cancer with other types of cancers, breast cancer is considered as the second cause of death in women." | 1.91 | Laser ablation of asphalt and coal in different solvents an In Vitro study. ( Al-Attar, HM; Alwan, AH; Mohammad, MH, 2023) |
| "Dimethyl sulfoxide (DMSO) is an excellent solvent for various types of anticancer drugs." | 1.62 | Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity. ( Fan, D; Wei, S; Xu, K; Yao, H; Zhou, L, 2021) |
| "We examined MSM in breast cancer cell lines and found it inhibited the proliferation of estrogen receptor-positive and HER2-positive breast cancer cells in a dose-dependent manner." | 1.43 | Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells. ( Byun, HJ; Darvin, P; Joung, YH; Kang, DY; Sp, N; Yang, YM; Yoo, YB, 2016) |
| "Here we studied the murine breast cancer cell line 66cl-4, because these cells are highly aggressive, potent inducers of metastasis and estrogen receptor negative." | 1.39 | Methyl sulfone manifests anticancer activity in a metastatic murine breast cancer cell line and in human breast cancer tissue--part I: murine 4T1 (66cl-4) cell line. ( Bannon, M; Caron, JM; O'Donovan, L; Rosshirt, L, 2013) |
| "Breast cancer is the most aggressive form of all cancers, with high incidence and mortality rates." | 1.38 | Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways. ( Cho, BW; Darvin, P; Do Park, K; Hong, DY; Hwang, TS; Joung, YH; Kim, SY; Lee, HK; Lim, EJ; Moon, ES; Na, YM; Park, JH; Park, T; Yang, YM; Ye, SK, 2012) |
| " Depending on dosage (0." | 1.35 | A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice. ( Doerge, DR; Helferich, WG; Ju, YH, 2008) |
| "PCs were collected from 14 women with breast cancer by a single plateletapheresis and cryopreserved in ThromboSol/2% DMSO by either direct insertion in a -80 degrees C freezer or in liquid nitrogen after computer-controlled rate (CR) freezing." | 1.31 | Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study. ( Balduini, CL; Belletti, S; Da Prada, GA; Noris, P; Pedrazzoli, P; Perotti, C; Ponchio, L; Robustelli Della Cuna, G; Salvaneschi, L; Schiavo, R; Siena, S, 2000) |
| "MCF-7 human breast carcinoma cultures grown in the presence of 17-beta estradiol form solid, multicellular nodules, a process that reflects changes in cell-substrate adhesions and loss of growth inhibition." | 1.30 | Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells. ( Bartholomew, PJ; DePasquale, JA; Vinci, JM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.84) | 18.7374 |
| 1990's | 11 (21.57) | 18.2507 |
| 2000's | 15 (29.41) | 29.6817 |
| 2010's | 17 (33.33) | 24.3611 |
| 2020's | 4 (7.84) | 2.80 |
| Authors | Studies |
|---|---|
| Desideri, I | 1 |
| Lucidi, S | 1 |
| Francolini, G | 1 |
| Meattini, I | 1 |
| Ciccone, LP | 1 |
| Salvestrini, V | 1 |
| Valzano, M | 1 |
| Morelli, I | 1 |
| Angelini, L | 1 |
| Scotti, V | 1 |
| Bonomo, P | 1 |
| Greto, D | 1 |
| Terziani, F | 1 |
| Becherini, C | 1 |
| Visani, L | 1 |
| Livi, L | 1 |
| Al-Attar, HM | 1 |
| Mohammad, MH | 1 |
| Alwan, AH | 1 |
| Xu, K | 1 |
| Yao, H | 1 |
| Fan, D | 1 |
| Zhou, L | 1 |
| Wei, S | 1 |
| Massiah, G | 1 |
| De Palma, G | 1 |
| Negri, A | 1 |
| Mele, F | 1 |
| Loisi, D | 1 |
| Paradiso, AV | 1 |
| Ressa, CM | 1 |
| Schultze, E | 1 |
| Coradini, K | 1 |
| Dos Santos Chaves, P | 1 |
| da Silva, LP | 1 |
| Buss, J | 1 |
| Guterres, SS | 1 |
| Collares, T | 1 |
| Beck, RCR | 1 |
| Pohlmann, AR | 1 |
| Seixas, FK | 1 |
| Gou, Y | 1 |
| Zhang, Z | 1 |
| Li, D | 1 |
| Zhao, L | 1 |
| Cai, M | 1 |
| Sun, Z | 1 |
| Li, Y | 1 |
| Zhang, Y | 1 |
| Khan, H | 1 |
| Sun, H | 1 |
| Wang, T | 1 |
| Liang, H | 1 |
| Yang, F | 1 |
| Ponnapakkam, T | 1 |
| Saulsberry, T | 1 |
| Hill, T | 1 |
| Hill-Odom, M | 1 |
| Goyal, N | 1 |
| Anbalagan, M | 1 |
| Liu, J | 1 |
| Foroozesh, M | 1 |
| Matlou, GG | 1 |
| Oluwole, DO | 1 |
| Prinsloo, E | 1 |
| Nyokong, T | 1 |
| Hammoudeh, SM | 1 |
| Hammoudeh, AM | 1 |
| Hamoudi, R | 1 |
| Caron, JM | 2 |
| Bannon, M | 2 |
| Rosshirt, L | 1 |
| O'Donovan, L | 1 |
| Monteagudo, L | 1 |
| Sanders, M | 1 |
| Deckers, PJ | 1 |
| Fleita, DH | 1 |
| Sakka, OK | 1 |
| Mohareb, RM | 1 |
| Aigner, B | 1 |
| Bauernhofer, T | 1 |
| Petru, E | 1 |
| Niederkorn, A | 1 |
| Arzberger, EJ | 1 |
| Richtig, E | 1 |
| S P, N | 1 |
| Darvin, P | 3 |
| Yoo, YB | 2 |
| Joung, YH | 3 |
| Kang, DY | 2 |
| Kim, DN | 1 |
| Hwang, TS | 2 |
| Kim, SY | 2 |
| Kim, WS | 1 |
| Lee, HK | 2 |
| Cho, BW | 2 |
| Kim, HS | 1 |
| Park, KD | 1 |
| Park, JH | 2 |
| Chang, SH | 1 |
| Yang, YM | 3 |
| Bergamo, A | 2 |
| Gerdol, M | 1 |
| Lucafò, M | 1 |
| Pelillo, C | 1 |
| Battaglia, M | 1 |
| Pallavicini, A | 1 |
| Sava, G | 1 |
| Sp, N | 1 |
| Byun, HJ | 1 |
| Davison, Z | 1 |
| Dutkowski, C | 1 |
| Gee, JM | 1 |
| Nicholson, RI | 1 |
| Heard, CM | 1 |
| She, QB | 1 |
| Chandarlapaty, S | 1 |
| Ye, Q | 1 |
| Lobo, J | 1 |
| Haskell, KM | 1 |
| Leander, KR | 1 |
| DeFeo-Jones, D | 1 |
| Huber, HE | 1 |
| Rosen, N | 1 |
| Yang, L | 1 |
| Cui, F | 1 |
| Shi, K | 1 |
| Cun, D | 1 |
| Wang, R | 1 |
| Karimi-Busheri, F | 1 |
| Zadorozhny, V | 1 |
| Shawler, DL | 1 |
| Fakhrai, H | 1 |
| Davidson, D | 1 |
| Grenier, J | 1 |
| Martinez-Marignac, V | 1 |
| Amrein, L | 1 |
| Shawi, M | 1 |
| Tokars, M | 1 |
| Aloyz, R | 1 |
| Panasci, L | 1 |
| Bratsos, I | 1 |
| Simonin, C | 1 |
| Zangrando, E | 1 |
| Gianferrara, T | 1 |
| Alessio, E | 1 |
| Lim, EJ | 1 |
| Hong, DY | 1 |
| Na, YM | 1 |
| Ye, SK | 1 |
| Moon, ES | 1 |
| Do Park, K | 1 |
| Park, T | 1 |
| Zhang, F | 1 |
| Koh, GY | 1 |
| Hollingsworth, J | 1 |
| Russo, PS | 1 |
| Stout, RW | 1 |
| Liu, Z | 1 |
| Corsini, J | 1 |
| Maxwell, F | 1 |
| Maxwell, IH | 1 |
| Syme, R | 1 |
| Bewick, M | 1 |
| Stewart, D | 1 |
| Porter, K | 1 |
| Chadderton, T | 1 |
| Glück, S | 1 |
| Bilir, A | 1 |
| Guneri, AD | 1 |
| Altinoz, MA | 1 |
| Lin, CH | 1 |
| Lin, PH | 1 |
| Ju, YH | 1 |
| Doerge, DR | 1 |
| Helferich, WG | 1 |
| Cyran, CC | 1 |
| Sennino, B | 1 |
| Chaopathomkul, B | 1 |
| Fu, Y | 1 |
| Rogut, V | 1 |
| Shames, DM | 1 |
| Wendland, MF | 1 |
| McDonald, DM | 1 |
| Brasch, RC | 1 |
| Rosenfeld, CS | 1 |
| Gremba, C | 1 |
| Shadduck, RK | 1 |
| Zeigler, ZR | 1 |
| Nemunaitis, J | 1 |
| Planchon, SM | 1 |
| Wuerzberger, S | 1 |
| Frydman, B | 1 |
| Witiak, DT | 1 |
| Hutson, P | 1 |
| Church, DR | 1 |
| Wilding, G | 1 |
| Boothman, DA | 1 |
| Eby, LL | 1 |
| Schepers, KG | 1 |
| Shulman-Roskes, EM | 1 |
| Noga, SJ | 1 |
| Davis, JM | 1 |
| Galmés, A | 1 |
| Besalduch, J | 1 |
| Bargay, J | 1 |
| Matamoros, N | 1 |
| Morey, M | 1 |
| Novo, A | 1 |
| Sampol, A | 1 |
| Murphy, LC | 1 |
| Huzel, N | 1 |
| Davie, JR | 1 |
| Anderson, HJ | 1 |
| Coleman, JE | 1 |
| Andersen, RJ | 1 |
| Roberge, M | 1 |
| Telang, NT | 1 |
| Katdare, M | 1 |
| Bradlow, HL | 1 |
| Osborne, MP | 1 |
| Jain, PT | 1 |
| Gewirtz, DA | 1 |
| Bartholomew, PJ | 1 |
| Vinci, JM | 1 |
| DePasquale, JA | 1 |
| Del Bino, G | 1 |
| Darzynkiewicz, Z | 1 |
| Degraef, C | 1 |
| Mosselmans, R | 1 |
| Fokan, D | 1 |
| Galand, P | 1 |
| Jardine, LJ | 1 |
| Milne, DM | 1 |
| Dumaz, N | 1 |
| Meek, DW | 1 |
| Pedrazzoli, P | 1 |
| Noris, P | 1 |
| Perotti, C | 1 |
| Schiavo, R | 1 |
| Ponchio, L | 1 |
| Belletti, S | 1 |
| Da Prada, GA | 1 |
| Balduini, CL | 1 |
| Salvaneschi, L | 1 |
| Robustelli Della Cuna, G | 1 |
| Siena, S | 1 |
| Fischer, WH | 1 |
| Keiwan, A | 1 |
| Schmitt, E | 1 |
| Stopper, H | 1 |
| Del Mastro, L | 1 |
| Venturini, M | 1 |
| Viscoli, C | 1 |
| Bergaglio, M | 1 |
| Signorini, A | 1 |
| Bighin, C | 1 |
| Bertelli, G | 1 |
| Semino, C | 1 |
| Pietra, G | 1 |
| Bertoglio, S | 1 |
| Sertoli, MR | 1 |
| Lambiase, A | 1 |
| Rosso, R | 1 |
| Melioli, G | 1 |
| Jackson, A | 1 |
| Davis, J | 1 |
| Pither, RJ | 1 |
| Rodger, A | 1 |
| Hannon, MJ | 1 |
| Bos, AM | 1 |
| van der Graaf, WT | 1 |
| Willemse, PH | 1 |
| Vashisht Gopal, YN | 1 |
| Konuru, N | 1 |
| Kondapi, AK | 1 |
| Wasserman, L | 1 |
| Nordenberg, J | 1 |
| Beery, E | 1 |
| Deutsch, AA | 1 |
| Novogrodsky, A | 1 |
| Zorina, LA | 2 |
| Bardychev, MS | 1 |
| Degtiarev, VA | 1 |
| Steinberg, A | 1 |
2 reviews available for dimethyl sulfoxide and Breast Neoplasms
| Article | Year |
|---|---|
Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexrazoxane; Dim | 2014 |
Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anticarcinogenic Agents; Benzo(a)pyrene; Biomarkers; Breast; Breas | 1997 |
3 trials available for dimethyl sulfoxide and Breast Neoplasms
| Article | Year |
|---|---|
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).
Topics: Aromatase Inhibitors; Arthralgia; Boswellia; Breast Neoplasms; Bromelains; Dietary Supplements; Dime | 2022 |
The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Topics: Adolescent; Adult; Breast Neoplasms; Cell Count; Cell Survival; Cryopreservation; Dimethyl Sulfoxide | 2004 |
A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant.
Topics: Adult; Blood Preservation; Breast Neoplasms; Cryopreservation; Dimethyl Sulfoxide; Female; Freezing; | 1995 |
46 other studies available for dimethyl sulfoxide and Breast Neoplasms
| Article | Year |
|---|---|
Laser ablation of asphalt and coal in different solvents an In Vitro study.
Topics: Breast Neoplasms; Coal; Dimethyl Sulfoxide; Ethanol; Female; Humans; Laser Therapy; MCF-7 Cells; Sol | 2023 |
Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Cross-Linking Reagents; | 2021 |
Cryopreservation of adipose tissue with and without cryoprotective agent addition for breast lipofilling: A cytological and histological study.
Topics: Adipose Tissue; Breast Neoplasms; Cryopreservation; Cryoprotective Agents; Dimethyl Sulfoxide; Femal | 2021 |
Drug-loaded nanoemulsion as positive control is an alternative to DMSO solutions for in vitro evaluation of curcumin delivery to MCF-7 cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Curcumin; Delayed-Action Preparations; Dimethyl Sulfoxide; | 2017 |
HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Dimethyl Sulfoxide; D | 2018 |
Inhibition of breast tumor growth in mice after treatment with ceramide analog 315.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Ceramides; Dimethyl Sulfoxide; F | 2018 |
Photodynamic therapy activity of zinc phthalocyanine linked to folic acid and magnetic nanoparticles.
Topics: Breast Neoplasms; Cell Survival; Dimethyl Sulfoxide; Female; Folic Acid; Humans; Indoles; Isoindoles | 2018 |
High-throughput quantification of the effect of DMSO on the viability of lung and breast cancer cells using an easy-to-use spectrophotometric trypan blue-based assay.
Topics: A549 Cells; Breast Neoplasms; Cell Survival; Dimethyl Sulfoxide; Humans; Lung Neoplasms; Spectrophot | 2019 |
Methyl sulfone manifests anticancer activity in a metastatic murine breast cancer cell line and in human breast cancer tissue--part I: murine 4T1 (66cl-4) cell line.
Topics: Actins; Animals; Antineoplastic Agents; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement | 2013 |
Methyl sulfone manifests anticancer activity in a metastatic murine breast cancer cell line and in human breast cancer tissue--part 2: human breast cancer tissue.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Movement; Cells, Cultured; Dimethyl S | 2013 |
Synthesis, structure activity relationships and biological activity evaluation of novel spirocyclic thiazolidin-4-ones as potential anti-breast cancer and epidermal growth factor receptor inhibitors.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; E | 2014 |
The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferati | 2015 |
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dimethyl Sulfoxide; Female; Gene Expressi | 2015 |
Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Female; Gene Expression | 2016 |
In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin.
Topics: Administration, Cutaneous; Animals; Breast Neoplasms; Cell Line, Tumor; Chromones; Cyclooxygenase 2; | 2008 |
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.
Topics: Breast Neoplasms; Cell Cycle; Dimethyl Sulfoxide; Female; G1 Phase; Gene Amplification; Humans; Phos | 2008 |
Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique.
Topics: Breast Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Chemistry, Pharmaceutical; D | 2009 |
The stability of breast cancer progenitor cells during cryopreservation: Maintenance of proliferation, self-renewal, and senescence characteristics.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cell Survival; Cellular Sen | 2010 |
Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells.
Topics: Acridones; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cisplatin; Comet Assay; Dimethyl Sulfoxid | 2012 |
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Coordination Complexes; Crystallography, X-Ray; | 2011 |
Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell S | 2012 |
Reformulation of etoposide with solubility-enhancing rubusoside.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Dimethyl S | 2012 |
Storage of various cell lines at -70 degrees C or -80 degrees C in multi-well plates while attached to the substratum.
Topics: Animals; Breast Neoplasms; Cats; Cell Adhesion; Cell Line; Cell Survival; Cold Temperature; Cryopres | 2002 |
Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro.
Topics: Acetaminophen; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidant | 2004 |
Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
Topics: Benzoflavones; Breast Neoplasms; Catalase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cytoch | 2006 |
A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
Topics: Acetates; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cimicifuga | 2008 |
Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.
Topics: Animals; Biotin; Breast Neoplasms; Contrast Media; Dimethyl Sulfoxide; Endothelium, Vascular; Female | 2008 |
Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antigens, CD; Antigens, CD34; Blood Transfusion, Autologous; Bone Marrow Transpla | 1994 |
Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response.
Topics: Apoptosis; Breast Neoplasms; Camptothecin; Cell Division; Dimethyl Sulfoxide; Drug Screening Assays, | 1995 |
Concentration of large volume peripheral blood stem cell products using the COBE 2991.
Topics: Blood Component Removal; Breast Neoplasms; Cell Count; Colony-Forming Units Assay; Dimethyl Sulfoxid | 1994 |
Novel DNase I hypersensitive sites in the 3'-flanking region of the human c-myc gene.
Topics: Base Sequence; Breast Neoplasms; Deoxyribonuclease I; Dimethyl Sulfoxide; DNA; DNA-Binding Proteins; | 1996 |
Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Dimethyl Sulfoxide; Drug Screening Ass | 1997 |
Enhancement of liposomal gene delivery in human breast cancer cells by dimethyl sulfoxide.
Topics: Breast Neoplasms; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Ethanol; Gene Transfer Techn | 1998 |
Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells.
Topics: Breast Neoplasms; Cell Adhesion; Cell Adhesion Molecules; Cytoskeletal Proteins; Dimethyl Sulfoxide; | 1998 |
Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Camptothecin; Cytologica | 1999 |
Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification.
Topics: Adenosine Triphosphate; Amino Acid Motifs; Amino Acid Substitution; Animals; Breast Neoplasms; Cells | 1999 |
Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.
Topics: Blood Transfusion, Autologous; Breast Neoplasms; Cryopreservation; Cryoprotective Agents; Dimethyl S | 2000 |
Increased formation of micronuclei after hormonal stimulation of cell proliferation in human breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; E | 2001 |
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Centrifugation | 2001 |
Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells.
Topics: Biological Transport; Breast Neoplasms; Catalysis; Dimethyl Sulfoxide; Endoplasmic Reticulum; Ethiny | 2001 |
A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2001 |
Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Colonic Neoplasms; Dimethyl Sulfoxi | 2002 |
Differential effects of sodium butyrate and dimethylsulfoxide on gamma-glutamyl transpeptidase and alkaline phosphatase activities in MCF-7 breast cancer cells.
Topics: Alkaline Phosphatase; Breast Neoplasms; Butyrates; Butyric Acid; Cell Differentiation; Cell Division | 1987 |
[Treatment of late radiation injuries of the lung appearing after radiotherapy of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Dimethyl Sulfoxide; Female; Humans; Middle | 1988 |
[Late radiation injuries of lungs after combined therapy in breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Dimethyl Sulfoxide; Female; Humans; Middle | 1986 |
The employment of dimethyl sulfoxide as an antiinflammatory agent and steroid-transporter in diversified clinical diseases.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Breast Neoplasms; Dimethyl Sulfoxide; Drug Synergism | 1967 |